Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Bachem Holding AG ( (CH:BANB) ) has provided an update.
Bachem Holding AG has announced the appointment of Hans Van Hees as the new Chief Operations Officer (COO) and member of the Executive Committee, effective September 1, 2025. This strategic move aims to enhance Bachem’s global production network, following significant progress in its operations and capacity expansions under CEO Thomas Meier’s interim leadership as COO. Hans Van Hees brings extensive experience from his previous roles at Johnson & Johnson and Janssen, which is expected to further strengthen Bachem’s industry positioning.
The most recent analyst rating on (CH:BANB) stock is a Buy with a CHF77.00 price target. To see the full list of analyst forecasts on Bachem Holding AG stock, see the CH:BANB Stock Forecast page.
More about Bachem Holding AG
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. It provides pharmaceutical and biotechnology companies worldwide with products for research, clinical development, and commercial application. Headquartered in Switzerland, Bachem operates internationally with locations in Europe, the USA, and Asia, and has over 50 years of experience and industry-leading expertise.
Average Trading Volume: 122,703
Technical Sentiment Signal: Strong Buy
Current Market Cap: CHF5.17B
Learn more about BANB stock on TipRanks’ Stock Analysis page.